Skip to main content
. 2016 May 26;101(9):3459–3468. doi: 10.1210/jc.2015-4275

Table 1.

Comparison of Serum and FF Immunoassay Results: Stratified by Study Group and Also by BMI, Controls Versus PCOS and Lean (BMI < 25) Versus Overweight (BMI ≥ 25 kg/m2)

Controls (n = 26) PCOS (n = 22) P Value Lean (n = 31) Overweight (n = 17) P Value
Age, y 31.8 ± 6.4 30.4 ± 4.3 NSa 31.7 ± 6.0 30.4 ± 4.9 NSa
BMI, kg/m2 23.8 ± 5.3 25.9 ± 4.9 NSa 21.8 ± 2.1 30.1 ± 4.7 na
Serum AMH, ng/mL 3.0 (1.0, 3.8) 6.4 (4.6, 8.2) <.00001b 3.8 (1.9, 5.1) 4.5 (2.8, 6.4) NSb
HOMA-IR 1.4 ± 0.93 1.4 ± 0.95 NSb 0.9 ± 0.49 2.0 ± 0.95 .006b
Serum CRP, mg/L 3.4 (1.7, 6.6) 2.5 (1.5, 10.1) NSb 2.1 (1.3, 6.2) 4.7 (2.2, 8.8) NSb
Serum TNFα, pg/mL 0.87 ± 0.11 0.88 ± 0.14 NSa 0.87 ± 0.13 0.88 ± 0.14 NSa
Serum IL-6, pg/mL 1.56 ± 1.16 1.40 ± 0.73 NSb 1.31 ± 1.03 1.66 ± 0.69 .046b
Serum T, ng/dL 36.0 (21.6, 60.8) 55.0 (38.2, 98.0) NSb 35.5 (21.6, 51.4) 66.7 (42.5, 102.6) .02b
FAI 0.70 (0.58, 0.90) 2.11 (1.23, 2.77) .009b 0.70 (0.58, 1.01) 2.11 (1.33. 3.01) .003b
FF IL-6, pg/mL 6.4 (5.0, 10.8) 8.4 (6.7, 24.2) .07b 7.3 (5.1, 12.4) 8.4 (6.4, 13.0) NSb
FF CRP, mg/L 1.36 (0.53, 3.64) 1.90 (0.57, 4.12) NSb 1.25 (0.56, 2.98) 3.97 (0.56, 7.94) NSb
FF TNFα, pg/mL 0.72 ± 0.16 0.64 ± 0.13 NSa 0.70 ± 0.15 0.58 ± 0.04 NSa
FF IL-8, pg/mL 118.0 (46.3, 177.7) 122.3 (94.3, 165.6) NSb 114.4 (66.0, 163.4) 130.1 (81.3, 221.3) NSb
FF T, ng/dL 648 (425, 922) 523 (467, 674) NSb 515 (413, 816) 726 (523, 979) .08b
FF Estradiol, pg/mL 210 070 (81 300; 370 205) 148 305 (73 464; 293 540) NSb 145 045 (73 324; 348 735) 293 540 (148 305; 370 205) NSb

Abbreviations: AMH, antimullerian hormone; BMI, body mass index; na, not applicable; NS, nonsignificant. Data are shown as mean ± SD or median (interquartile range).

a

Comparison with a two-sample t test.

b

Comparison with a Mann-Whitney test.